Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02414672 · ClinicalTrials.gov registry record · NA

CareSTEPS: A Supportive Care Program for the Caregivers of Advanced Lung Cancer Patients

A NA study of Lung Cancer, sponsored by Baylor College of Medicine.

Completed
Registry status
NA
Development phase
317
Enrollment target
1
Study location

NCT02414672 is a NA study of Lung Cancer that has completed, run by Baylor College of Medicine. The registered enrollment target is 317 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02414672, a NA study of Lung Cancer, has completed, sponsored by Baylor College of Medicine.

COMPLETED
Registry status
NA
Development phase
317 participants
Enrollment target
1
Study location

Study Summary

The CareSTEPS intervention fills an important service gap by providing education, skills training, and support to the caregivers of advanced lung cancer patients on active treatment. The home-based delivery format will facilitate future dissemination and outreach. By empowering families with the skills they need to provide care and meet the challenges of lung cancer, this intervention holds great promise for improving caregiver quality of life (QOL), patient QOL, and the quality of palliative and supportive care services offered to patients with advanced cancer and their families.

Conditions Studied

Interventions

  • BEHAVIORAL CareSTEPS

Study Locations (1)

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 317 participants
Start Date 2014-11
Est. Completion 2020-12
Phase NA

Sponsor

Baylor College of Medicine

616 total trials

What the Registry Record Tells You About NCT02414672

The ClinicalTrials.gov registry entry for NCT02414672 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 317 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (66% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which CareSTEPS is the first listed.

NCT02414672 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02414672 about?

NCT02414672 is a clinical study titled "CareSTEPS: A Supportive Care Program for the Caregivers of Advanced Lung Cancer Patients". The CareSTEPS intervention fills an important service gap by providing education, skills training, and support to the caregivers of advanced lung cancer patients on active treatment. The home-based delivery format will facilitate future dissemination and outreach. By empowering families with the ski...

What is the current status of trial NCT02414672?

This trial is currently completed. It is a NA study. The enrollment target is 317 participants. The study started on 2014-11. Estimated completion is 2020-12.

What conditions does trial NCT02414672 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT02414672?

The interventions under investigation include: CareSTEPS (BEHAVIORAL).

Who is sponsoring clinical trial NCT02414672?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02414672 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.